A detailed history of Pathstone Holdings, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pathstone Holdings, LLC holds 347,234 shares of AZN stock, worth $24.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
347,234
Previous 335,531 3.49%
Holding current value
$24.3 Million
Previous $26.2 Million 3.39%
% of portfolio
0.12%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$76.67 - $87.62 $897,269 - $1.03 Million
11,703 Added 3.49%
347,234 $27.1 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $396,116 - $479,241
5,929 Added 1.8%
335,531 $26.2 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $7.14 Million - $8.14 Million
116,985 Added 55.02%
329,602 $22.3 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $13.2 Million - $14.7 Million
212,617 New
212,617 $14.3 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $216B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.